Compounds > megestrol acetate
Page last updated: 2024-08-21

megestrol acetate and Bone Loss, Osteoclastic

megestrol acetate has been researched along with Bone Loss, Osteoclastic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bailey, MC; Bain, SD; Celino, DL; Edwards, MW; Jensen, E; Lantry, MM1
Hao, XJ; Li, RT; Mu, QZ; Tan, NH; Zeng, GZ1

Other Studies

2 other study(ies) available for megestrol acetate and Bone Loss, Osteoclastic

ArticleYear
High-dose gestagens modulate bone resorption and formation and enhance estrogen-induced endosteal bone formation in the ovariectomized mouse.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1993, Volume: 8, Issue:2

    Topics: Analysis of Variance; Animals; Bone Development; Bone Resorption; Estradiol; Female; Femur; Megestrol; Megestrol Acetate; Mice; Mice, Inbred BALB C; Norethindrone; Norethindrone Acetate; Osteoclasts; Ovariectomy; Progesterone Congeners; Radioimmunoassay; Random Allocation; Spine; Tibia

1993
Natural inhibitors targeting osteoclast-mediated bone resorption.
    Bioorganic & medicinal chemistry letters, 2006, Dec-15, Volume: 16, Issue:24

    Topics: Bone Resorption; Cathepsin K; Cathepsins; Drug Design; Enzyme Inhibitors; Humans; Integrin alphaVbeta3; Matrix Metalloproteinase Inhibitors; Osteoclasts; Protease Inhibitors

2006